Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 6


Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis.

Eisele YS, Obermüller U, Heilbronner G, Baumann F, Kaeser SA, Wolburg H, Walker LC, Staufenbiel M, Heikenwalder M, Jucker M.

Science. 2010 Nov 12;330(6006):980-2. doi: 10.1126/science.1194516. Epub 2010 Oct 21.


Hereditary and sporadic forms of abeta-cerebrovascular amyloidosis and relevant transgenic mouse models.

Kumar-Singh S.

Int J Mol Sci. 2009 Apr 23;10(4):1872-95. doi: 10.3390/ijms10041872. Review.


Alzheimer disease: a tale of two prions.

Nussbaum JM, Seward ME, Bloom GS.

Prion. 2013 Jan-Feb;7(1):14-9. doi: 10.4161/pri.22118. Epub 2012 Sep 10. Review.


Biomarker evidence for uncoupling of amyloid build-up and toxicity in Alzheimer's disease.

Zetterberg H, Blennow K.

Alzheimers Dement. 2013 Jul;9(4):459-62. doi: 10.1016/j.jalz.2012.07.002. Epub 2012 Nov 14. Review.


Abeta aggregation and possible implications in Alzheimer's disease pathogenesis.

Bharadwaj PR, Dubey AK, Masters CL, Martins RN, Macreadie IG.

J Cell Mol Med. 2009 Mar;13(3):412-21. doi: 10.1111/j.1582-4934.2009.00609.x. Review.


Prions, prionoids and pathogenic proteins in Alzheimer disease.

Ashe KH, Aguzzi A.

Prion. 2013 Jan-Feb;7(1):55-9. doi: 10.4161/pri.23061. Epub 2012 Dec 3. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk